| Literature DB >> 27328636 |
Keiki Ogino1, Yasushi Obase2,3, Tatsuo Ito4, Masaki Fujimura5, Eri Eguchi1, Masayuki Kubo1, Kenjiro Nagaoka1, Hiroyuki Nakamura6.
Abstract
The relationship between serum arginase I and serum l-arginine or fractional exhaled nitric oxide (FENO) was evaluated cross-sectionally in asthmatic patients. No sex difference was observed in the serum mean levels of arginase I and l-arginine or FENO. Arginase I and FENO were higher in patients 60 or younger years than in those over 60 years. Asthmatic patients were divided into three groups: no steroid therapy, inhalation steroid therapy, and oral steroid therapy. Arginase I, FENO and high-sensitivity-C-reactive protein (hs-CRP) were significantly lower in the inhalation steroid therapy group than in the no steroid therapy group. Correlations were observed between arginase I and FENO, l-arginine, hs-CRP, WBC, and age, and also between FENO and IgE, WBC, and age. A logistic regression analysis revealed the positive association of arginase I with FENO, and the negative association of l-arginine. FENO was positively associated with arginase I and IgE. These results indicated that serum arginase I might influence serum levels of l-arginine and FENO, and that IgE might influence FENO in asthmatic patients.Entities:
Keywords: Arginase I; clinical study; fractional exhaled nitric oxide (FENO); l-arginine
Mesh:
Substances:
Year: 2016 PMID: 27328636 DOI: 10.1080/10715762.2016.1202407
Source DB: PubMed Journal: Free Radic Res ISSN: 1029-2470